4//SEC Filing
O'Dowd Sarah A 4
Accession 0001104659-25-001434
CIK 0001377121other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:10 PM ET
Size
7.5 KB
Accession
0001104659-25-001434
Insider Transaction Report
Form 4
O'Dowd Sarah A
Director
Transactions
- Award
Common Stock
2025-01-02+5,130→ 5,130 total - Award
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 totalExercise: $38.98Exp: 2035-01-02→ Common Stock (6,584 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date.
- [F2]The stock option vests in 12 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001447149
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:10 PM ET
- Size
- 7.5 KB